The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Imoxicate 100 mg/25 mg spot-on solution for medium dogs

100,25 mg/pipette Spot-on solution

Krka, d.d., Novo mestoVPA10774/067/002

Main Information

Trade NameImoxicate 100 mg/25 mg spot-on solution for medium dogs
Active SubstancesImidacloprid
Strength100,25 mg/pipette
Dosage FormSpot-on solution
Licence HolderKrka, d.d., Novo mesto
Licence NumberVPA10774/067/002

Group Information

ATC CodeQP54AB52 moxidectin, combinations
Therapeutic ClassEndectoparasiticides


Licence Issued13/03/2020
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
« Back